Abbott Laboratories (ABT)

Index:

S&P 100

$ 133.72
   
  • Change Today:
    $-1.48
  • 52 Week High: $140.22
  • 52 Week Low: $100.07
  • Currency: US Dollars
  • Shares Issued: 1,731.70m
  • Volume: 3,402,393
  • Market Cap: $231,563m
  • RiskGrade: 113
  • Beta: 0.23

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Continuing Operations          
Revenue 41,950.00 40,109.00 43,653.00 43,075.00 34,608.00
Operating Profit/(Loss) 6,825.00 6,478.00 8,362.00 8,425.00 5,357.00
Profit Before Tax 7,013.00 6,664.00 8,306.00 8,211.00 4,968.00
Profit After Tax 13,402.00 5,723.00 6,933.00 7,071.00 4,471.00
           
Earnings per Share - Basic 767.00¢ 328.00¢ 394.00¢ 4.01¢ 252.00¢
Earnings per Share - Adjusted 767.00¢ 328.00¢ 394.00¢ 4.01¢ 252.00¢
           
Dividend per Share 224.00¢ 208.00¢ 192.00¢ 1.84¢ 153.00¢
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Assets          
Non-Current Assets          
Property, Plant & Equipment 10,658.00 10,154.00 9,162.00 8,959.00 9,029.00
Intangible Assets 29,755.00 32,494.00 33,253.00 35,970.00 38,528.00
Other Non-Current Assets 17,345.00 7,896.00 6,033.00 6,028.00 3,729.00
  57,758.00 50,544.00 48,448.00 50,957.00 51,286.00
Current Assets          
Inventories 6,194.00 6,570.00 6,173.00 5,157.00 5,012.00
Cash at Bank & in Hand 7,616.00 6,896.00 9,882.00 9,799.00 6,838.00
Other Current Assets 9,846.00 9,204.00 9,169.00 9,283.00 9,412.00
  23,656.00 22,670.00 25,224.00 24,239.00 21,262.00
           
Other Assets n/a n/a 766.00 n/a n/a
Total Assets 81,414.00 73,214.00 74,438.00 75,196.00 72,548.00
Current Liabilities          
Borrowings 1,500.00 1,080.00 2,251.00 754.00 220.00
Other Current Liabilities 12,657.00 12,761.00 13,238.00 12,351.00 11,687.00
           
Current Liabilities 14,157.00 13,841.00 15,489.00 13,105.00 11,907.00
           
Net Current Assets c9,499.00 c8,829.00 c9,735.00 c11,134.00 c9,355.00
           
Borrowings 12,625.00 13,599.00 14,522.00 17,296.00 18,527.00
Other Non-Current Liabilities 6,731.00 6,947.00 7,522.00 8,771.00 9,111.00
Non-Current Liabilities 19,356.00 20,546.00 22,044.00 26,067.00 27,638.00
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 33,513.00 34,387.00 37,533.00 39,172.00 39,545.00
           
Net Assets 47,901.00 38,827.00 36,905.00 36,024.00 33,003.00
           
Shareholders Funds 47,664.00 38,603.00 36,686.00 35,802.00 32,784.00
           
Minority Interests/Other Equity 237.00 224.00 219.00 222.00 219.00
Total Equity 47,901.00 38,827.00 36,905.00 36,024.00 33,003.00
Cash Flow 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Net Cash Flow From Operating Activities 8,558.00 7,261.00 9,581.00 10,533.00 7,901.00
Net Cash Flow from Investing Activities (2,338.00) (3,133.00) (1,740.00) (2,008.00) (2,215.00)
Net Cash Flow from Financing Activities (5,500.00) (7,114.00) (7,758.00) (5,564.00) (2,708.00)
Net Increase/Decrease In Cash 720.00 (2,986.00) 83.00 2,961.00 2,978.00
Ratios - based on IFRS 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Continuing Operations          
PE Ratio - Adjusted 14.7 33.6 27.9 3,512.1 43.4
PEG - Adjusted 0.1 n/a 0.0 n/a 2.0
Earnings per Share Growth - Adjusted 134% -17% 9,732% -98% 22%
Dividend Cover 3.42 1.58 2.05 2.18 1.65
Revenue per Share 2,422.48¢ 2,316.17¢ 2,520.82¢ 25.11¢ 1,998.50¢
Pre-Tax Profit per Share 404.98¢ 384.82¢ 479.64¢ 4.79¢ 286.89¢
Operating Margin 16.27% 16.15% 19.16% 19.56% 15.48%
Return on Capital Employed 21.73% 31.72% 40.67% 0.46% 37.57%
           
Dividend Yield 2.0% 1.9% 1.7% 0.0% 1.4%
Dividend per Share Growth 7.69% 8.33% 10,351.18% (98.80%) 15.91%
Operating Cash Flow per Share 494.20¢ 419.30¢ 553.27¢ 6.14¢ 456.26¢
Cash Incr/Decr per Share 41.58¢ (172.43¢) 4.79¢ 1.73¢ 171.97¢
Net Asset Value per Share (exc. Intangibles) 1,047.87¢ 365.71¢ 210.89¢ 3.12¢ (319.05¢)
Net Gearing 13.66% 20.16% 18.78% 23.05% 36.33%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Top of Page